May 9, 2008
YM Biosciences Reports Fiscal Third Quarter 2008 Operational and Financial Results
“During the quarter we continued to advance nimotuzumab globally, leveraging co-operative efforts of multiple partners and other licensees of the drug”
YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today reported operational and financial results for its third quarter of ... via Med Ad News
Comments
|
Joined: May 11, 2008
Comments: 46
|
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| What's Lurking in Your Granite Countertop? | 6 hr | Huligar | 1 |
| New findings on radon and granite countertops | 6 hr | Steven Nenzel | 1 |
| No. 2 on Cuba's export list may surprise some | Thu | 26th Latitude | 5 |
| New findings on radon and granite countertops | Thu | Pamela | 6 |
| letters | Thu | www | 3 |
| my soninlaws stage 4 lung cancer miracle (from Aug '06) | Thu | JSpross Au... | 86 |
| Friends support Gardner woman battling cancer w... | Wed | Danielle | 7 |

